China Acne & Atopic Dermatitis Dermocosmetic Products Market is segmented By Product Type (Cleansers, Moisturizers/Lotions, Face cream, Lotion, Cleansing Oil, Cleansing Mask, Serum, Body Wash, Toner, Face Wash, Others), By Application (Acne, Atopic Dermatitis (AD)), By Distribution Channel (Retail Stores, E-Commerce), and By Region – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
The China Acne & Atopic Dermatitis Dermocosmetic Products Market is expected to grow at a CAGR of 7% during the forecast period (2024-2031).
Market Scope
Metrics |
Details |
Market CAGR |
7% |
Segments Covered |
By Product Type, By Application, By Distribution Channel, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
For more details on this report Request for Sample
China is expected to be a booming market for acne and atopic dermatitis dermo-cosmetics products over the forecast period (2019-2026), as Chinese consumers are willing to pay for branded or premium products and are less price sensitive. The major players are dominating the personal care products market in China, with the majority of three being foreign brands. The three largest sellers in China currently are Procter and Gamble, L’Oreal, Galderma SA, and Pierre-Fabre SA. This trend is also reflected in domestic production, with over 80% of products produced via foreign-owned or joint ventures. The distribution channels for dermo-cosmetic products are changing rapidly, reflecting consumer distrust of mass-market channels the upgrading of Chinese consumer preferences, and the growing middle class in Tier 2 and Tier 3 cities. The dermo-cosmetics market exemplifies more than 4.5% of the China beauty market.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the dermo-cosmetics market in China. For instance,
In February 2019, L’Oréal S.A. launched a digital skin diagnostic technology for consumers. This development was possible owing to the acquisition of augmented reality and artificial intelligence entity, Modiface Inc.
In October 2019, L'Oréal announced a strategic investment in Cathay Innovation, a global venture capital fund founded to support entrepreneurs engaged in the sustainable transformation of the world through technology. With this transaction, L'Oréal strengthens its connection to the beauty tech startup ecosystem, particularly in China, the group's second-largest market, and a pioneer in digital innovation.
China Acne & Atopic Dermatitis Dermocosmetic Products Market Dynamics
The presence of major dermo-cosmetic brands such as L’Oreal, Pierre Fabre, among others in China is boosting the growth of the market.
The L'Oréal Group, the world's largest cosmetics and beauty company, has introduced four cosmeceuticals brands - Vichy, La Roche-Posay, SkinCeuticals, and CeraVe - in China through the Active Cosmetics Division. In the first half of 2018, the division reported sales of 1.4 billion U.S. dollars, achieving a like-for-like growth of 11.4%.
In May 2019, at Viva Technology Paris 2019, L’Oréal and Alibaba Group jointly announced the arrival of La Roche-Posay’s Effaclar Spotscan app on Alibaba’s Tmall and Taobao platforms, making the technology available to consumers in China. Effaclar Spotscan by L’Oréal’s La Roche-Posay brand is the world’s first web app providing analysis of acne-prone skin.
Winona, a local brand that has emerged as “cosmeceuticals” and “dermatologist/medical skincare” and achieved great success in China, is shifting to strengthen its positioning for sensitive skin supported by dermatology.
Also, as the fourth brand from the group’s Active Cosmetics Division in China, CeraVe claimed itself to be an expert on dry/sensitive skin barrier repair recommended by American dermatologists.
Another major player Pierre Fabre also has a slew of cosmeceutical brands, such as Avène, Rene Furterer, Klorane, and A-Derma. According to the Activity and Corporate Social Responsibility Report 2017-2018, the world's second-largest dermo-cosmetics laboratory's Dermo-Cosmetics division pocketed 1.6 billion U.S. dollars in net sales in 2017. The company's brand Avene is one of the most popular skincare brands in China. Pierre Fabre is also keen to introduce more brands to Chinese consumers
The evolving demand of Chinese consumers creates ample opportunities for dermo-cosmetic product developers. In recent decades, almost all globally leading cosmetic brands have launched distribution in China. For instance, the launch of Vichy and La Roche-Posay launched several products for acne and eczema treatment.
The acne and atopic dermatitis dermo-cosmetics market in China represents a particularly high share of the cosmetic market (40%). There are several well-established presences of dermo-cosmetics brands in China which are mostly opted by consumers.
China’s dermo-cosmetics market is going through a premiumization stage, in which local consumers are willing to pay a higher price for higher quality products. Well-established foreign brands are highly benefited from the premiumization as the local consumers still consider them as trustworthy and reliable. International brands can, therefore, capitalize on their Western origins and expertise to establish their reputation and nurture consumer trust.
INDUSTRY FORCES
China has implemented some stringent regulations on the cosmetics industry.
The China Food and Drug Administration (CFDA) has shone a spotlight on the country's cosmetic marketing policies, in regard to "medical" cosmetics, or cosmeceuticals, a booming segment for Chinese consumers.
The policies were published on Jan. 10, 2019, in a collection of answers to frequently asked questions (FAQs) on cosmetic supervision and management by the National Medical Product's Administration. In the wake of these policies, marketers and formulators may need to prove their products contain only sanctioned ingredients and remove illegal claims and products.
China's FAQs state that products registered as cosmetics are banned from including terms such as medicated cosmetic or medical skincare products. This is based on Articles 12 and 14 of the current Regulations on Cosmetic Hygiene Supervision in China. Since the release of the FAQs, many of China's eCommerce platforms and cosmetic brands have reportedly removed products containing medical claims. The Implementation of the Regulations on Cosmetics Hygienic Supervision states that, when a cosmetic product is first imported into China, its foreign manufacturer or agent must obtain and complete an Application Form for Hygiene License of Imported Cosmetics from the relevant hygiene administration department. They must submit their applications directly to the hygiene administration department under the State Council. Products that pass the inspection will be issued with an Approval Document for Hygiene License of Imported Cosmetics which is valid for four years.
China Acne & Atopic Dermatitis Dermocosmetic Products Market Segmentation
By Product Type
The Cleansers segment of China Acne and Atopic Dermatitis Dermocosmetic Products Market is valued at US$ XX Million in 2018 and is estimated to grow at a CAGR of 7% over the forecast period to reach US$ XX Million by 2026.
The collective revenue of the Cleansers segment is expected to generate US$ XX Million during 2019-2026.
The Cleansers segment holds XX% of the market share in 2018 and is expected to be XX% by 2026, for China Acne and Atopic Dermatitis Dermocosmetic Products Market by Product Type.
Cleansers are products used to remove the normal accumulation of dirt and oils, makeup, sunscreen, remains of pollution, and dead skin cells. It refreshes the skin and gives the complexion a chance to breathe.
Cleansers unclog the pores of the skin, hence decreasing the chances of developing acne and other skin problems.
The market for cleansers is growing in China due to emerging trends, that have a direct impact on the dynamics of the facial cleanser industry, such as the use of hyaluronic acid and retinol for anti-aging and anti-acne properties, micellar waters for water management, cannabis skincare as antioxidants, and probiotic skincare for delivering good bacteria to the skin
According to a study conducted 67% of female respondents express a preference for the use of highly specialized skincare products that can solve specific problems. The respondents with higher household incomes are more inclined to use highly specialized skincare products. According to this study, 68% of the females in the country uses cleanser daily as an essential product.
The Chinese beauty industry is continuously growing and environmental situations such as high pollution and humidity are driving the growth of cleansers in the country.
L'Oréal and Johnson and Johnson are two major companies in the region that are manufacturing and marketing cleansers in the market.
Cleansing oils are another option to remove makeup, surface debris, and excess oil. What makes them different is how they work compared to traditional water-soluble cleansers that have a cream, gel, or foaming texture.
Normal cleansers leave the skin feeling squeaky clean and create an acid mantle that is too acidic. When the acid mantle is unbalanced, the skin will up its production of sebum so it can rebalance to its happy pH level. When the oil arrives at the surface of the skin if the surface is too acidic, it might not be able to get out and this is when one can get congestion or acne.
Oil cleansers don't change the acid mantle at all. Oil cleansers are so gentle that they usually don't need to be followed by a moisturizer.
Hence, the market for cleansing oil is expected to grow at a high pace due to a highly beauty aware population with greasy, oily and acne-prone skin